NL-OMON36047招募中不适用
Pilot study using Fluorine-18 Sodium Fluoride PET/CT in diagnosing of skeletal metastases in men with prostate cancer. - Pilotstudy Sodium Fluoride PET/CT
Isala Klinieken0 个研究点目标入组 90 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 90
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational non invasive
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •De novo prostate cancer, and
- •Informed consent, and
- •indication for bone scintigraphy
排除标准
- •oncologic history, and
- •on hormon treatment, and
- •unable to tolerate PET/CT
研究者
相似试验
进行中（未招募）
1 期
18F-fluoride PET for Early Non-invasive Assessment of Cortical Bone Formation - Non-invasive Assessment of Cortical Bone Formation - Version 1EUCTR2009-016523-61-GBKing’s College London30
已完成
2 期
F-18 Sodium Fluoride in Prostate CancerProstate NeoplasmNCT01240551National Cancer Institute (NCI)60
进行中（未招募）
不适用
Phase III clinical study of PET-TC with [18f]Fluoroethyilcholine ([18f]Fech) in prostate cancer: assessment of the additional role with respec to conventional imaging techniquesMedDRA version: 14.1Level: PTClassification code 10060862Term: Prostate cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)prostate cancerEUCTR2012-004297-26-ITPOLICLINICO UNIVERSITARIO AGOSTINO GEMELLI750
招募中
2 期
FET PET in Differentiating Tumour Progression From Pseudoprogression in High Grade GliomaGlioma, MalignantNCT06172595Singapore General Hospital22
已完成
2 期
Fluorine F 18 Sodium Fluoride Positron Emission Tomography in Evaluating Response to Dasatinib in Patients With Prostate Cancer and Bone MetastasesHormone-Resistant Prostate CancerMetastatic Malignant Neoplasm in the BoneRecurrent Prostate CarcinomaStage IV Prostate CancerNCT00936975National Cancer Institute (NCI)18